Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ELITEK
- Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome
- Effect of Reducing Uric Acid on Insulin Sensitivity and Oxidative Status
- Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies
- Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2
- Mature B-Cell Lymphoma And Leukemia Study III
- Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS
- Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
Clinical trials list
click for details